Literature DB >> 9274986

Antiretroviral agent (R)-9-(2-phosphonomethoxypropyl)adenine stimulates cytokine and nitric oxide production.

Z Zídek1, A Holý, D Franková.   

Abstract

The immunomodulatory properties of (R)-enantiomer of 9-(2-phoshonomethoxypropyl)adenine ((R)-PMPA), one of the most potent acyclic nucleotide analogs effective against human immunodeficiency virus (HIV), were investigated under in vitro conditions using murine peritoneal macrophages. Remaining without influence on interferon-gamma and interleukin-2 expression, (R)-PMPA dramatically stimulated in a concentration- and time-dependent manner the secretion of tumor necrosis factor alpha (TNF-alpha) and interleukin-10. It also substantially augmented the production of nitric oxide (NO) induced by exogenous interferon-gamma. Inhibitory experiments using neutralizing antibodies against TNF-alpha and/or interleukin-10 demonstrated that these two cytokines are major factors responsible for triggering the underlying mechanism(s) leading to enhanced NO production. The novel findings on the immunomodulatory potential of acyclic nucleotide analogs are discussed in the context of their possible implication in antiviral therapeutic efficacy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9274986     DOI: 10.1016/s0014-2999(97)01004-2

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment.

Authors:  J D Lifson; J L Rossio; R Arnaout; L Li; T L Parks; D K Schneider; R F Kiser; V J Coalter; G Walsh; R J Imming; B Fisher; B M Flynn; N Bischofberger; M Piatak; V M Hirsch; M A Nowak; D Wodarz
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 2.  Tenofovir disoproxil fumarate: a review of its use in the management of HIV infection.

Authors:  Katherine A Lyseng-Williamson; Neil A Reynolds; Greg L Plosker
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Activated memory CD4(+) T helper cells repopulate the intestine early following antiretroviral therapy of simian immunodeficiency virus-infected rhesus macaques but exhibit a decreased potential to produce interleukin-2.

Authors:  J J Mattapallil; Z Smit-McBride; P Dailey; S Dandekar
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

4.  9-[2-(Phosphonomethoxy)propyl]adenine (PMPA) therapy prolongs survival of infant macaques inoculated with simian immunodeficiency virus with reduced susceptibility to PMPA.

Authors:  K K Van Rompay; J M Cherrington; M L Marthas; P D Lamy; P J Dailey; D R Canfield; R P Tarara; N Bischofberger; N C Pedersen
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

5.  Reduced immune activation during tenofovir-emtricitabine therapy in HIV-negative individuals.

Authors:  Jose R Castillo-Mancilla; Amie Meditz; Cara Wilson; Jia-Hua Zheng; Brent E Palmer; Eric J Lee; Edward M Gardner; Sharon Seifert; Becky Kerr; Lane R Bushman; Samantha MaWhinney; Peter L Anderson
Journal:  J Acquir Immune Defic Syndr       Date:  2015-04-15       Impact factor: 3.731

Review 6.  Tenofovir disoproxil fumarate.

Authors:  Therese Chapman; Jane McGavin; Stuart Noble
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques.

Authors:  Karin J Metzner; James M Binley; Agegnehu Gettie; Preston Marx; Douglas F Nixon; Ruth I Connor
Journal:  Retrovirology       Date:  2006-12-21       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.